ERDOĞDU, N. Et Al. 2021. Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer. 13th Internation symposium of Pharmaceutical Science , (Ankara, Turkey).

ERDOĞDU, N., Akkın, S., VARAN, G., & BİLENSOY, E., (2021). Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer . 13th Internation symposium of Pharmaceutical Science, Ankara, Turkey

ERDOĞDU, NAZLI Et Al. "Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer," 13th Internation symposium of Pharmaceutical Science, Ankara, Turkey, 2021

ERDOĞDU, NAZLI Et Al. "Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer." 13th Internation symposium of Pharmaceutical Science , Ankara, Turkey, 2021

ERDOĞDU, N. Et Al. (2021) . "Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer." 13th Internation symposium of Pharmaceutical Science , Ankara, Turkey.

@conferencepaper{conferencepaper, author={NAZLI ERDOĞDU Et Al. }, title={Development and Characterization of Erlotinib-Randomly Methylated-β-cyclodextrin Complex for the Treatment of Non-small Lung Cancer}, congress name={13th Internation symposium of Pharmaceutical Science}, city={Ankara}, country={Turkey}, year={2021}}